Literature DB >> 12100022

C-ANCA-positive IgG fraction from patients with Wegener's granulomatosis induces lung vasculitis in rats.

W Weidebach1, V S T Viana, E P Leon, C Bueno, A S Leme, F M Arantes-Costa, M A Martins, P H N Saldiva, E Bonfa.   

Abstract

The aim of the present study was to analyse in rats the ability of C-ANCA-positive IgG fraction in triggering inflammatory response on pulmonary tissue. Wistar rats (n = 18) were injected via the the internal jugular vein with 20 mg of total C-ANCA-positive IgG fraction isolated from serum of three different Wegener's granulomatosis patients obtained before therapy. Similarly, control rats were treated with IgG fraction from two rheumatoid arthritis patients (n = 7), IgG from six normal human sera (n = 15) or saline (n = 18), respectively. Animals were sacrificed after 24h of injection for histological analysis of the lungs. Vasculitis and inflammatory infiltrate were consistently absent in rats injected with rheumatoid arthritis IgG or saline and in 14/15 of normal IgG treated animals. In contrast, marked vasculitis was observed in all 18 animals injected with C-ANCA-positive IgG fraction. The histological features were characterized by the presence of a perivascular pleomorphic cellular sheath, particularly around small vessels, endothelial adherence and diapedesis of polymorphonuclear leucocytes and presence of granuloma-like lesions. A dose-response relationship was observed between protein concentration of C-ANCA IgG sample and the intensity of the inflammatory response in the animals. In addition, IgG fraction with undetectable C-ANCA, obtained from one patient in remission after treatment, was not able to reproduce the pulmonary tissue alterations induced by its paired IgG that was positive for C-ANCA taken before therapy. The experimental model described herein may be useful to characterize more effectively the pathogenic mechanism of C-ANCA in Wegener's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12100022      PMCID: PMC1906412          DOI: 10.1046/j.1365-2249.2002.01888.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  37 in total

1.  Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies.

Authors:  M T Keogan; V L Esnault; A J Green; C M Lockwood; D L Brown
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

Review 2.  Do antineutrophil cytoplasmic autoantibodies cause Wegener's granulomatosis and other forms of necrotizing vasculitis?

Authors:  J C Jennette; B H Ewert; R J Falk
Journal:  Rheum Dis Clin North Am       Date:  1993-02       Impact factor: 2.670

3.  [Antineutrophil cytoplasmic antibodies in systemic vasculitis].

Authors:  A S Radu; C Bueno; E S Bonfá; W Cossermelli
Journal:  Rev Hosp Clin Fac Med Sao Paulo       Date:  1993 Nov-Dec

Review 4.  Cellular immune responses and pathogenesis in c-ANCA positive vasculitides.

Authors:  N Rasmussen; J Petersen
Journal:  J Autoimmun       Date:  1993-04       Impact factor: 7.094

5.  Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo.

Authors:  E Csernok; M Ernst; W Schmitt; D F Bainton; W L Gross
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

6.  Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration.

Authors:  M Blank; Y Tomer; M Stein; J Kopolovic; A Wiik; P L Meroni; G Conforti; Y Shoenfeld
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells.

Authors:  W J Mayet; A Schwarting; K H Meyer zum Büschenfelde
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

8.  Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis.

Authors:  C A Stegeman; J W Tervaert; W J Sluiter; W L Manson; P E de Jong; C G Kallenberg
Journal:  Ann Intern Med       Date:  1994-01-01       Impact factor: 25.391

Review 9.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

10.  Neutrophil activation in vitro and in vivo in Wegener's granulomatosis.

Authors:  E Brouwer; M G Huitema; A H Mulder; P Heeringa; H van Goor; J W Tervaert; J J Weening; C G Kallenberg
Journal:  Kidney Int       Date:  1994-04       Impact factor: 10.612

View more
  4 in total

Review 1.  Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.

Authors:  Maria C Cid; Marta Segarra; Ana García-Martínez; Jose Hernández-Rodríguez
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

2.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

3.  Anti-endothelial cell antibodies (AECA) in patients with propylthiouracil (PTU)-induced ANCA positive vasculitis are associated with disease activity.

Authors:  F Yu; M-H Zhao; Y-K Zhang; Y Zhang; H-Y Wang
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

4.  Experimental autoimmune vasculitis: an animal model of anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis.

Authors:  Mark A Little; Lucy Smyth; Alan D Salama; Sriparna Mukherjee; Jennifer Smith; Dorian Haskard; Sussan Nourshargh; H Terence Cook; Charles D Pusey
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.